Delivery Order SPE2DB22D3011-SPE2DB24FQ3DY
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,881.48 firm-fixed-price delivery order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE, a specialty drug medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds several significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which serve as primary vehicles for...
This federal contract award, with the ID SPE2DB20D2001|SPE2DB25FPMJG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, and has a ceiling value of $1,574.56. The contract type is Delivery Order with a Firm Fixed Price pricing model, and the ultimate completion date is April 1, 2025. The...
This federal contract award, identified as SPE2DB22D1103|SPE2DB25FTFE4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $15,573.69, is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is February 6, 2025. The...
This federal contract award, with the identifier SPE2DB24D3013|SPE2DB24FFGFU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,729.64 firm-fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML medication. The contract has a completion date of July 17, 2024 and does not utilize a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal...
This federal contract award, identified as SPE2DX15D3021|SPE2DX24F1LK6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $2,702.81 and a completion date of May 2, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp, a major supplier...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB24FJ2RJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,025.00, is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, with ID SPE2DB22D3004 and SPE2DB25FNU24, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,276.99 firm fixed-price delivery order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DB20D2104|SPE2DB25FMGBW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a ceiling value of $1,920.36 and a completion date of January 15, 2025. The contract was awarded on January 14,...
This federal contract award, with ID SPE2DB22D1200|SPE2DB25FM9HF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,504.16 firm fixed-price delivery order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FY49M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, which is not set aside, is for the delivery of 4,566,076,532 units of the drug COSENTYX SENSOREADY 150 MG PENML. The contract has a ceiling value of $64,212.39 and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 11, 2024....